Response to Villanacci et. al

Affiliations

¹ Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
² Department of Pathology and Laboratory Medicine, Mt Sinai Hospital, Toronto, ON, Canada.
³ Department of Pathology and Laboratory Medicine, Mt Sinai Hospital, Toronto, ON, Canada rriddell@mtsinai.on.ca.

Comment

R V Bryant et al. J Crohns Colitis. 2015 May.

. 2015 May;9(5):429.

doi: 10.1093/ecco-jcc/jjv046. Epub 2015 Mar 11.

¹ Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford University Hospitals, Oxford, UK.
² Department of Pathology and Laboratory Medicine, Mt Sinai Hospital, Toronto, ON, Canada.
³ Department of Pathology and Laboratory Medicine, Mt Sinai Hospital, Toronto, ON, Canada rriddell@mtsinai.on.ca.

No abstract available

Comment on

Systematic review: histological remission in inflammatory bowel disease. Is 'complete' remission the new treatment paradigm? An IOIBD initiative.
Bryant RV, Winer S, Travis SP, Riddell RH. Bryant RV, et al. J Crohns Colitis. 2014 Dec;8(12):1582-97. doi: 10.1016/j.crohns.2014.08.011. Epub 2014 Sep 27. J Crohns Colitis. 2014. PMID: 25267173
Histological remission in inflammatory bowel disease: where are we, and where are we going?
Villanacci V, Bassotti G, Langner C. Villanacci V, et al. J Crohns Colitis. 2015 May;9(5):428. doi: 10.1093/ecco-jcc/jjv043. Epub 2015 Mar 4. J Crohns Colitis. 2015. PMID: 25740814 No abstract available.